trending Market Intelligence /marketintelligence/en/news-insights/trending/zj9lmwrqvgow6qjdfctfdw2 content esgSubNav
In This List

Atara Biotherapeutics starts $150M common stock offering

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


Atara Biotherapeutics starts $150M common stock offering

Atara Biotherapeutics Inc. is selling $150 million of its common shares in an underwritten public offering.

The company also expects to grant the underwriters an option to buy up to an additional $22.5 million of common shares.

J.P. Morgan and Cowen are acting as joint book-running managers for the proposed offering.